Diagnóstico prick control negativo

DRUG5 trials

Sponsors

Advanced Outcomes Research S.L., Asac Pharmaceutical Inmunology S.A., Asac Pharmaceutical Inmunology S.A., Advanced Outcomes Research S.L., Asac Pharmaceutical Inmunology S.A.

Conditions

Allergies

Phase 2

In vivo biological standardization of Dermatophagoides allergen extracts.

WithdrawnCTIS2024-514108-15-00

Advanced Outcomes Research S.L., Asac Pharmaceutical Inmunology S.A.Allergies

Target: 96Updated: 2024-09-09

In vivo biological standardization of Dermatophagoides allergen extracts.

Active, not recruitingCTIS2024-514108-15-01

Advanced Outcomes Research S.L., Asac Pharmaceutical Inmunology S.A.Allergies

Start: 2025-04-11Target: 36Updated: 2025-03-14

In vivo biological standardization of Lepidoglyphus destructor allergen extract

Not yet recruitingCTIS2025-520753-37-00

Asac Pharmaceutical Inmunology S.A., Advanced Outcomes Research S.L.Allergies

Target: 36Updated: 2025-08-13

In vivo biological standardization of Blomia tropicalis allergen extract.

Not yet recruitingCTIS2025-520711-14-00

Advanced Outcomes Research S.L., Asac Pharmaceutical Inmunology S.A.Allergies

Target: 36Updated: 2025-08-14

In vivo biological standardization of Olea europaea allergen extracts.

Not yet recruitingCTIS2025-523866-26-00

Asac Pharmaceutical Inmunology S.A.Allergies

Target: 36Updated: 2026-02-25